A detailed history of Jacobs Levy Equity Management, Inc transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 191,726 shares of ENTA stock, worth $1.22 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
191,726
Previous 194,567 1.46%
Holding current value
$1.22 Million
Previous $2.52 Million 21.2%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.05 - $16.54 $28,552 - $46,990
-2,841 Reduced 1.46%
191,726 $1.99 Million
Q2 2024

Aug 14, 2024

SELL
$11.43 - $17.02 $1,863 - $2,774
-163 Reduced 0.08%
194,567 $2.52 Million
Q1 2024

May 15, 2024

SELL
$10.08 - $17.46 $3.69 Million - $6.4 Million
-366,291 Reduced 65.29%
194,730 $3.4 Million
Q4 2023

Feb 14, 2024

BUY
$8.18 - $10.78 $1.76 Million - $2.32 Million
215,370 Added 62.31%
561,021 $5.28 Million
Q3 2023

Nov 16, 2023

SELL
$11.09 - $22.13 $18,819 - $37,554
-1,697 Reduced 0.49%
345,651 $3.86 Million
Q2 2023

Aug 14, 2023

BUY
$20.68 - $39.85 $18,467 - $35,586
893 Added 0.26%
347,348 $7.43 Million
Q1 2023

May 15, 2023

SELL
$38.82 - $54.59 $101,048 - $142,097
-2,603 Reduced 0.75%
346,455 $14 Million
Q4 2022

Feb 14, 2023

SELL
$40.77 - $53.73 $132,298 - $174,353
-3,245 Reduced 0.92%
349,058 $16.2 Million
Q3 2022

Nov 15, 2022

BUY
$48.29 - $71.27 $2.64 Million - $3.9 Million
54,771 Added 18.41%
352,303 $18.3 Million
Q2 2022

Aug 15, 2022

BUY
$38.13 - $76.93 $728,626 - $1.47 Million
19,109 Added 6.86%
297,532 $14.1 Million
Q1 2022

May 16, 2022

BUY
$56.06 - $74.11 $464,905 - $614,594
8,293 Added 3.07%
278,423 $19.8 Million
Q4 2021

Feb 14, 2022

BUY
$60.19 - $97.37 $982,060 - $1.59 Million
16,316 Added 6.43%
270,130 $20.2 Million
Q3 2021

Nov 15, 2021

SELL
$41.02 - $58.65 $235,413 - $336,592
-5,739 Reduced 2.21%
253,814 $14.4 Million
Q2 2021

Aug 16, 2021

BUY
$43.76 - $53.11 $756,872 - $918,590
17,296 Added 7.14%
259,553 $11.4 Million
Q1 2021

May 17, 2021

SELL
$41.69 - $54.95 $252,766 - $333,161
-6,063 Reduced 2.44%
242,257 $11.9 Million
Q4 2020

Feb 16, 2021

SELL
$41.16 - $47.47 $318,743 - $367,607
-7,744 Reduced 3.02%
248,320 $10.5 Million
Q3 2020

Nov 16, 2020

SELL
$43.36 - $53.53 $355,421 - $438,785
-8,197 Reduced 3.1%
256,064 $11.7 Million
Q2 2020

Aug 17, 2020

BUY
$46.37 - $57.58 $4.33 Million - $5.38 Million
93,476 Added 54.73%
264,261 $13.3 Million
Q1 2020

May 15, 2020

BUY
$40.22 - $62.0 $3.42 Million - $5.27 Million
84,998 Added 99.08%
170,785 $8.78 Million
Q4 2019

Feb 14, 2020

BUY
$57.95 - $66.61 $835,233 - $960,049
14,413 Added 20.19%
85,787 $5.3 Million
Q3 2019

Nov 14, 2019

BUY
$60.08 - $88.17 $803,269 - $1.18 Million
13,370 Added 23.05%
71,374 $4.29 Million
Q2 2019

Aug 13, 2019

BUY
$81.3 - $97.35 $4.72 Million - $5.65 Million
58,004 New
58,004 $4.89 Million
Q4 2018

Feb 14, 2019

SELL
$65.41 - $84.65 $1.75 Million - $2.27 Million
-26,822 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$85.46 - $126.37 $1.21 Million - $1.79 Million
14,145 Added 111.58%
26,822 $2.29 Million
Q2 2018

Aug 14, 2018

SELL
$81.85 - $120.51 $1.31 Million - $1.93 Million
-16,043 Reduced 55.86%
12,677 $1.47 Million
Q1 2018

May 15, 2018

SELL
$57.91 - $92.15 $39,378 - $62,662
-680 Reduced 2.31%
28,720 $2.32 Million
Q4 2017

Feb 13, 2018

BUY
$45.65 - $59.37 $1.34 Million - $1.75 Million
29,400
29,400 $1.73 Million

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $132M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.